A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma

Cervical Cancer

(2017) Benjamin E. Greer et al.   Journal of the National Comprehensive Cancer Network

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study

(2012) David S. Alberts et al.   GYNECOLOGIC ONCOLOGY

A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer

(2012) Ryo Kitagawa et al.   GYNECOLOGIC ONCOLOGY

Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study

(2012) Munetaka Takekuma et al.   GYNECOLOGIC ONCOLOGY

Chemotherapy for advanced and recurrent cervical carcinoma: Results from cooperative group trials

(2012) Charles A. Leath et al.   GYNECOLOGIC ONCOLOGY

A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma

(2010) Lisa A. Kottschade et al.   CANCER

Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy

(2010) Maki Tanioka et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell Lung Cancer

(2010) Craig Reynolds et al.   Journal of Thoracic Oncology

Novel chemotherapy approaches for cervical cancer

(2009) Sujana Movva et al.   CANCER

Phase II Evaluation of Nanoparticle Albumin–Bound Paclitaxel in Platinum-Sensitive Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

(2009) Michael G. Teneriello et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study

(2009) Bradley J. Monk et al.   JOURNAL OF CLINICAL ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER